The battle against pediatric cancer remains one of the most emotionally charged and urgent challenges in modern healthcare, impacting thousands of young lives across the United States each year with diagnoses that shatter families and communities. Despite progress in medical science, many children
In the fast-evolving world of pharmaceuticals, the first half of this year has delivered a stunning reshuffle in the hierarchy of blockbuster drugs, with Novo Nordisk’s Ozempic and Eli Lilly’s Mounjaro vaulting into the top three revenue earners. This dramatic rise, fueled by an insatiable demand
In a groundbreaking development that bridges traditional healthcare research with cutting-edge blockchain technology, a Nasdaq-listed cancer research company has unveiled a staggering $344.4 million digital asset treasury, marking a significant pivot from its core mission of AI-driven drug
The intersection of severe influenza during pregnancy and its potential to harm fetal brain development has emerged as a critical concern for both expectant mothers and medical professionals, prompting urgent attention. A pioneering study conducted by researchers at the University of Illinois
Pulmonary arterial hypertension (PAH), a life-threatening condition characterized by dangerously high blood pressure in the lung arteries, has long posed significant challenges for patients and clinicians alike due to its progressive nature and limited treatment options. Enter sotatercept, a
Imagine a promising biotech company, poised to revolutionize treatment for a debilitating skin condition, only to see its stock value obliterated overnight by disappointing trial results. This is the reality for Moonlake Immunotherapeutics, a Swiss-based firm that witnessed an 80% plunge in its
